1.
Haznedaroglu I. MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML). MJHID [Internet]. 31Dec.2013 [cited 24May2019];6(1):e2014009. Available from: http://www.mjhid.org/index.php/mjhid/article/view/2014.009